Alzheimer’s Disease Neuroimaging Initiative

4453 Total Publications

Year	Title	Author	Journal
2015	A computational atlas of the hippocampal formation using ex vivo, ultra-high resolution MRI: Application to adaptive segmentation of in vivo MRI	Iglesias, J. E., Augustinack, J. C., Nguyen, K., Player, C. M., Player, A., Wright, M., … Van Leemput, K.	Journal Neuroimage;
2015	Optimizing Regions-of-Interest Composites for Capturing Treatment Effects on Brain Amyloid in Clinical Trials.	Tryputsen, V., DiBernardo, A., Samtani, M., Novak, G. P., Narayan, V. A., & Raghavan, N.	Journal Journal of Alzheimer's Disease;
2015	Brain Amyloid-􏰀 Burden Is Associated with Disruption of Intrinsic Functional Connectivity within the Medial Temporal Lobe in Cognitively Normal Elderly	Song Z1, Insel PS2, Buckley S2, Yohannes S3, Mezher A2, Simonson A2, Wilkins S4, Tosun D2, Mueller S2, Kramer JH4, Miller BL4, Weiner MW5.	Journal J Neurosci;
2015	Round robin test on quantification of amyloid-β 1–42 in cerebrospinal fluid by mass spectrometry	J. Pannee, J. Gobom, L. M. Shaw, M. Korecka, E. E. Chambers, M. Lame, R. Jenkins, W. Mylott, M. C. Carrillo, I. Zegers, H. Zetterberg, K. Blennow and E. Portelius	Journal Alzheimers Dement;
2015	Ferritin levels in the cerebrospinal fluid predict Alzheimer’s disease outcomes and are regulated by APOE	Ayton, S., Faux, N. G., & Bush, A. I.	Journal Nature Communications;
2015	A potential endophenotype for Alzheimer’s disease: cerebrospinal fluid clusterin	Y. Deming, J. Xia, Y. Cai, J. Lord, P. Holmans, S. Bertelsen, D. Holtzman, J. C. Morris, K. Bales, E. H. Pickering, J. Kauwe, A. Goate, C. Cruchaga and I. Alzheimer's Disease Neuroimaging	Journal Neurobiol Aging;
2015	Depressive symptoms accelerate cognitive decline in amyloid-positive MCI patients	Brendel, M., Pogarell, O., Xiong, G., Delker, A., Bartenstein, P., & Rominger, A.	Journal European Journal of Nuclear Medicine and Molecular Imaging;
2015	Alzheimer's disease biomarkers as outcome measures for clinical trials in MCI	Caroli, A., Prestia, A., Wade, S., Kewei, C., Ayutyanont, N., Landau, S., … Initiative, for the A. D. N.	Journal Alzheimer's Disease and Associated Disorders;
2015	Improved Power for Characterizing Longitudinal Amyloid-b PET Changes and Evaluating Amyloid-Modifying Treatments with a Cerebral White Matter Reference Region	Chen K1, Roontiva A2, Thiyyagura P2, Lee W2, Liu X2, Ayutyanont N2, Protas H2, Luo JL2, Bauer R2, Reschke C2, Bandy D2, Koeppe RA3, Fleisher AS4, Caselli RJ5, Landau S6, Jagust WJ6, Weiner MW7, Reiman EM8; Alzheimer’s Disease Neuroimaging Initiative.	Journal J Nucl Med;
2015	Amyloid PET in European and North American cohorts; and exploring age as a limit to clinical use of amyloid imaging	Chiotis, K., Carter, S. F., Farid, K., Savitcheva, I., & Nordberg, A.	Journal European Journal of Nuclear Medicine and Molecular Imaging;